Biotech Firm Begins $100-Mil Expansion

WASHINGTON, DC-Biotechnology company Human Genome Sciences, Inc. breaks ground on a $100-million production facility to be housed adjacent to the company’s headquarters on the Belward Research Campus of Johns Hopkins University in Rockville, Maryland. The new structure will enable the company to manufacture more than one drug at a time for commercial use.

Currently, the company sits on a 27-acre lot, and manufactures drugs at its 127,000-sf plant in a quantity only large enough for testing purposes. With the new facility, Human Genome Sciences will produce novel human hormones and proteins, as well as human antibody drugs. “We appreciate the strong support of the financial community which has enabled Human Genome Sciences to finance this important expansion,” says company Senior Vice President Steven C. Mayer.